DIA 2013 49th Annual Meeting
Click here to go to the previous page
Using Legislation to Advance Regulatory Science: "I'm Just a Bill..."
Track
:
Track 10: Public Policy/ Health Care Compliance/ Law
Program Code:
313
Date:
Wednesday, June 26, 2013
Time:
8:00 AM to 9:30 AM
EST
Location:
154
CHAIR
:
Karen E. Jaffe, MBA,MS,MSc,RAC (SCHSUP), Life Sciences Professional, Alfred Mann Institute, United States
SPEAKER
(S):
Juergen Froehlich, MD,MBA,FFPM (SPKNON), Vice President, Global Regulatory Affairs, Vertex Pharmaceuticals, United States Marc M. Boutin, Esq, JD (SPKSUP), Executive Vice President and Chief Operating Officer, National Health Council, United States Carla Mann Woods, (SPKSUP), CEO and Founder, Fight to Live, United States
Description
Several legislations have been introduced calling for regulatory reform for the drug approval process. FDA is under pressure from industry to enable a regulatory framework for translational medicine but at the same time preserve the public health. This session will discuss impacts to the pharmaceutical industry and investment community as well as the patient community.
This session is a part of:
This session is a part of: